Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies
- 1Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education, Shanghai 200127, China
Abstract
Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.
Related
- VEGF Signaling and Targeted Therapies in Cancer: Molecular Mechanisms, Clinical Applications, Resistance, and Cardiorenal Toxicities
- Ubiquitination-Dependent Cyclin Regulation in Gastric Cancer and Emerging Targeted Therapies with Chinese Herbal Bioactive Compounds
- Targeted Modulation of the Gut Microbiota in Obesity: From Dietary Interventions to Bacteriophage-Based Precision Therapies
- Gut microbiome and aging-related disorders: mechanistic insights and emerging microbiome-targeted therapies for healthy aging.
- Chimeric models of neurodegenerative diseases: from disease mechanisms to regenerative therapies.
BibTeX
@article{zhang2026autophagy,
title = {{Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies}},
author = {Shuyu Zhang and Ying Li and Xuefang Shen and Qionghui Zhan},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210274},
url = {https://www.mdpi.com/1422-0067/27/22/10274},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies
AU - Shuyu Zhang
AU - Ying Li
AU - Xuefang Shen
AU - Qionghui Zhan
PY - 2026
DA - 2026/11/16
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210274
UR - https://www.mdpi.com/1422-0067/27/22/10274
AB - Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.
SN - 1422-0067
ER -